Bachem Holding AG
SIX:BANB

Watchlist Manager
Bachem Holding AG Logo
Bachem Holding AG
SIX:BANB
Watchlist
Price: 67.5 CHF -3.3% Market Closed
Market Cap: 5.1B CHF
Have any thoughts about
Bachem Holding AG?
Write Note

Bachem Holding AG
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bachem Holding AG
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Bachem Holding AG
SIX:BANB
Gross Profit
CHf179.4m
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
11%
Siegfried Holding AG
SIX:SFZN
Gross Profit
CHf332.2m
CAGR 3-Years
19%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Gross Profit
CHf2B
CAGR 3-Years
5%
CAGR 5-Years
-1%
CAGR 10-Years
7%
Tecan Group AG
SIX:TECN
Gross Profit
CHf346.7m
CAGR 3-Years
-7%
CAGR 5-Years
4%
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Gross Profit
€9.3m
CAGR 3-Years
-50%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Gross Profit
CHf240.6m
CAGR 3-Years
22%
CAGR 5-Years
107%
CAGR 10-Years
N/A
No Stocks Found

Bachem Holding AG
Glance View

Market Cap
5.1B CHF
Industry
Life Sciences Tools & Services

Bachem Holding AG engages in the provision of peptides and oligonucleotides. The company is headquartered in Bubendorf, Basel-Landschaft and currently employs 1,639 full-time employees. The company went IPO on 2001-06-29. The firm focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The firm markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

BANB Intrinsic Value
90.95 CHF
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Bachem Holding AG's Gross Profit?
Gross Profit
179.4m CHF

Based on the financial report for Jun 30, 2024, Bachem Holding AG's Gross Profit amounts to 179.4m CHF.

What is Bachem Holding AG's Gross Profit growth rate?
Gross Profit CAGR 10Y
11%

Over the last year, the Gross Profit growth was 13%. The average annual Gross Profit growth rates for Bachem Holding AG have been 5% over the past three years , 15% over the past five years , and 11% over the past ten years .

Back to Top